Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Tax Provisions (2022 - 2025)

Historic Tax Provisions for Arcturus Therapeutics Holdings (ARCT) over the last 4 years, with Q2 2025 value amounting to $4000.0.

  • Arcturus Therapeutics Holdings' Tax Provisions rose 10200.0% to $4000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$217000.0, marking a year-over-year decrease of 11625.47%. This contributed to the annual value of -$4000.0 for FY2024, which is 10021.8% down from last year.
  • As of Q2 2025, Arcturus Therapeutics Holdings' Tax Provisions stood at $4000.0, which was up 10200.0% from -$4000.0 recorded in Q4 2024.
  • In the past 5 years, Arcturus Therapeutics Holdings' Tax Provisions registered a high of $900000.0 during Q3 2023, and its lowest value of -$217000.0 during Q3 2024.
  • Its 4-year average for Tax Provisions is $192100.0, with a median of $101500.0 in 2022.
  • Examining YoY changes over the last 5 years, Arcturus Therapeutics Holdings' Tax Provisions showed a top increase of 28834.95% in 2024 and a maximum decrease of 13333.33% in 2024.
  • Quarter analysis of 4 years shows Arcturus Therapeutics Holdings' Tax Provisions stood at $100000.0 in 2022, then skyrocketed by 135.0% to $235000.0 in 2023, then plummeted by 101.7% to -$4000.0 in 2024, then soared by 200.0% to $4000.0 in 2025.
  • Its Tax Provisions was $4000.0 in Q2 2025, compared to -$4000.0 in Q4 2024 and -$217000.0 in Q3 2024.